KELLY MICHAEL GERALD 4
4 · RENOVIS INC · Filed Jan 18, 2006
Insider Transaction Report
Form 4
RENOVIS INCRNVS
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
- Sale
Common Stock
2006-01-17$18.18/sh−1,000$18,180→ 40,966 total - Award
Stock Option (Right to Buy)
2006-01-16+150,000→ 150,000 totalExercise: $18.18Exp: 2016-01-15→ Common Stock (150,000 underlying)
Footnotes (4)
- [F1]Disposition of securities made pursuant to a 10b5-1 plan adopted by Dr. Kelly on March 17, 2005.
- [F2]Includes 166 shares acquired through 401k employer match contribution.
- [F3]The option becomes vested and exercisable in substantially equal monthly installments over the 4-year period following the date of grant.
- [F4]not applicable